A piece of breaking news reaching our news desk indicates that the Food and Drugs Authority (FDA) has sacked the Head of Legal Affair, Mrs. Cynthia Dapaah-Ntow, over her bribery scandal.
Mrs. Cynthia Dapaah-Ntow was found her guilty of misconduct by a disciplinary committee.
The FDA instituted internal disciplinary proceedings against Cynthia Dapaah-Ntow following an investigation by the Editor-in-Chief of The Fourth Estate, Manasseh Azure Awuni, that implicated her in a bribery scandal.
The disciplinary committee requested and was given the television version of Manasseh’s investigative documentary even though Mrs. Cynthia Dapaah-Ntow, had sought an injunction against the broadcast in court.
An internal memo sent to the staff of the FDA Tuesday evening by the Head of Human Resource reads:
“Management would like to inform Staff that effective 18th May 2021, Mrs. Cynthia Dapaah-Ntow, Head of Legal, will cease to be a staff of the FDA. The decision was arrived at after Mrs. Cynthia Dapaah-Ntow was taken through the internal disciplinary process of the Authority, following a charge of misconduct leveled against her.
“The Disciplinary Committee recommended to the Board that the appointment of Mrs. Cynthia Dapaah-Ntow be terminated. The Board has subsequently accepted the recommendation and given her the required notice of termination of appointment.
“The Staff are also hereby informed that the Investigative Committee exonerated the CEO of all allegations of wrongdoing on her part.
“Management appreciates the patience exhibited by all Staff while the disciplinary process lasted.
“As a matured regulatory agency whose core values include transparency, fairness, and integrity, the Authority reiterates its zero-tolerance for bribery and corruption and reaffirms its commitments to the staff.”
US-based university denies Cynthia Dapaah-Ntow admission
Last week, The Fourth Estate broke the story of how Mrs. Cynthia Dapaah-Ntow was denied admission to the Thomas R. Kline School of Law at the Drexel University in Philadelphia, USA, because of “The Returned Bribe” investigation.
Mrs. Dapaah-Ntow had applied to study the LLM in Healthcare & Pharm Compliance for the Spring Semester of 20-21, but the admission team sent her the following response in an email:
“Thank you for applying to Drexel University. After careful consideration of your application, the Admissions Committee has determined that we are unable to offer you admission.”
Unsatisfied with the response and curious to know the reason for the denial of admission, the FDA lawyer wrote to the university to find out.
“I am passionate about the programme and would want to reapply,” she said in her letter. “I hope you will be kind enough to point to me what worked against me in my last application so I do not repeat the same in my next attempt.”
In a response sent by the Assistant Dean of Enrolment Management, Audrey Woods, on December 17, 2020, the university explained that the denial of admission had nothing to do with her academic credentials.
“We found you to be a very qualified candidate, however, it came to the attention of the admissions committee that you were under investigation for allegations of bribery which is not in line with our values and code of conduct,” the university said in an email to the FDA lawyer.
Details of the correspondence are part of court processes Mrs. Dapaah-Ntow filed to support a case in which she’s seeking an injunction from the court to stop the broadcast of the television version of “The Returned Bribe” an investigative documentary by the Editor-in-Chief of The Fourth Estate, Manasseh Azure Awuni.